BlackRock Amends Outset Medical Stake, Maintains Passive Investment
Ticker: OM · Form: SC 13G/A · Filed: Jan 26, 2024 · CIK: 1484612
Complexity: simple
Sentiment: neutral
Topics: institutional-ownership, amendment, passive-investment
Related Tickers: OM
TL;DR
**BlackRock still owns a big chunk of Outset Medical, signaling institutional confidence.**
AI Summary
BlackRock Inc. filed an amended Schedule 13G/A on January 26, 2024, indicating its ownership in Outset Medical, Inc. (NASDAQ: OM) as of December 31, 2023. This filing updates their previous disclosures, showing BlackRock's continued significant, but passive, investment in the medical device company. This matters to investors because it signals that a major institutional investor like BlackRock maintains a substantial stake, which can be seen as a vote of confidence in Outset Medical's long-term prospects, potentially influencing other investors.
Why It Matters
This filing confirms BlackRock's ongoing significant, passive ownership in Outset Medical, providing a signal of institutional confidence to current and prospective shareholders.
Risk Assessment
Risk Level: low — This is a routine update from a passive institutional investor and does not indicate any immediate risk or change in company operations.
Analyst Insight
Investors should note BlackRock's continued passive stake as a sign of institutional interest, but recognize this is a routine update and not an active investment decision change.
Key Players & Entities
- BlackRock Inc. (company) — the institutional investor filing the SC 13G/A
- Outset Medical, Inc. (company) — the subject company in which BlackRock holds shares
- December 31, 2023 (date) — the date of the event requiring the filing
- January 26, 2024 (date) — the filing date of the SC 13G/A
FAQ
What type of filing is this document?
This document is an SC 13G/A, which is an amendment to a Schedule 13G filing, indicating a change or update to previously reported beneficial ownership of securities.
Who is the 'reporting person' in this filing?
The reporting person, or the entity filing this statement, is BlackRock Inc., a major institutional investment manager.
What is the 'subject company' of this filing?
The subject company, whose securities are being reported, is Outset Medical, Inc., identified by CIK 0001484612 and located at 3052 Orchard Drive, San Jose, CA.
What is the 'Date of Event Which Requires Filing of this Statement'?
The date of the event which required the filing of this statement is December 31, 2023, as stated in the filing.
Under which rule is this Schedule 13G filed?
This Schedule 13G/A is filed under Rule 13d-1(b), as indicated by the 'X' in the appropriate box on the cover page.
Filing Details
This Form SC 13G/A (Form SC 13G/A) was filed with the SEC on January 26, 2024 regarding Outset Medical, Inc. (OM).